- Home
- MXCT vs EYPT Comparison
MXCT vs EYPT Comparison
Compare MXCT & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MXCT
- EYPT
- Stock Information
- Founded
- MXCT 1999
- EYPT 1987
- Country
- MXCT United States
- EYPT United States
- Employees
- MXCT N/A
- EYPT N/A
- Industry
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- MXCT Health Care
- EYPT Industrials
- Exchange
- MXCT Nasdaq
- EYPT Nasdaq
- Market Cap
- MXCT 398.3M
- EYPT 439.4M
- IPO Year
- MXCT 2021
- EYPT 2005
- Fundamental
- Price
- MXCT $3.45
- EYPT $8.35
- Analyst Decision
- MXCT Strong Buy
- EYPT Strong Buy
- Analyst Count
- MXCT 3
- EYPT 8
- Target Price
- MXCT $8.67
- EYPT $27.29
- AVG Volume (30 Days)
- MXCT 599.5K
- EYPT 1.3M
- Earning Date
- MXCT 11-06-2024
- EYPT 11-07-2024
- Dividend Yield
- MXCT N/A
- EYPT N/A
- EPS Growth
- MXCT N/A
- EYPT N/A
- EPS
- MXCT N/A
- EYPT N/A
- Revenue
- MXCT $45,599,000.00
- EYPT $45,713,000.00
- Revenue This Year
- MXCT N/A
- EYPT N/A
- Revenue Next Year
- MXCT $21.59
- EYPT N/A
- P/E Ratio
- MXCT N/A
- EYPT N/A
- Revenue Growth
- MXCT 19.85
- EYPT 7.50
- 52 Week Low
- MXCT $3.17
- EYPT $5.87
- 52 Week High
- MXCT $5.55
- EYPT $30.99
- Technical
- Relative Strength Index (RSI)
- MXCT 44.48
- EYPT 35.82
- Support Level
- MXCT $3.17
- EYPT $8.25
- Resistance Level
- MXCT $3.61
- EYPT $9.40
- Average True Range (ATR)
- MXCT 0.25
- EYPT 0.81
- MACD
- MXCT -0.01
- EYPT -0.43
- Stochastic Oscillator
- MXCT 28.93
- EYPT 2.35
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.